ENTX

Entera Bio Ltd. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website enterabio.com
Employees(FY) 19
ISIN IL0011429839

Performance

-7.19%

-16.22%

-4.32%

-36.48%

+158.33%

YTD

+112.33%

Profile

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. Its other product candidate is GLP-2, which is in preclinical trial for the treatment of short bowl syndrome; and hGh for the GH deficiency. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.

Advanced Technical Analysis

Technical Analysis of ENTX 2024-11-20

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 3, Oscillators Score at 36, and a Technical Score of 20, indicating overall weakness in price momentum and suggesting caution for potential investors. The low scores across all categories highlight a lack of bullish signals in the current market environment.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ENTX

Stock Rank

Recent News & Updates

2024-11-08 04:15
Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-11-08 03:05
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates(Globenewswire)
2024-09-24 20:30
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders(Globenewswire)
2024-09-17 21:40
Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year?(Yahoo Finance)
2024-09-01 21:40
Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?(Yahoo Finance)
2024-08-19 20:00
Entera Bio to Participate in Upcoming Investor and Scientific Conferences(Globenewswire)
2024-08-15 00:00
All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy(Yahoo Finance)
2024-08-09 04:05
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates(Globenewswire)
2024-07-31 20:30
Entera's EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual Meeting - Key SABRE Update Also Expected(Globenewswire)
2024-07-22 18:28
3 Meme Stocks to Buy and Hold for Potential 300% Returns in 3 Years(Yahoo Finance)
2024-07-08 03:53
3 Meme Stocks That Can Surge by 200% Before 2025(Investorplace)
2024-07-02 05:05
3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns(Investorplace)
2024-06-25 04:37
3 Meme Stocks to Buy on the Dip: June 2024(Investorplace)
2024-06-20 00:38
7 Penny Stocks to Turn $3 Into $1 Million Within 36 Months(Investorplace)
2024-06-19 18:47
Rags to Riches: 3 Penny Stocks That Could Make Early Investors Rich(Yahoo Finance)
2024-06-19 18:47
Rag to Riches: 3 Penny Stocks That Could Make Early Investors Rich(Investorplace)
2024-06-17 01:00
3 Penny Stocks to Turn $50,000 Into $1 Million: June 2024(Investorplace)
2024-06-10 07:22
Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024(Yahoo Finance)
2024-06-06 19:30
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar(Investorplace)
2024-06-02 21:40
Has Entera Bio (ENTX) Outpaced Other Medical Stocks This Year?(Zacks)
2024-06-02 20:00
Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024(Globenewswire)
2024-05-22 18:45
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom(Investorplace)
2024-05-15 21:40
Are Medical Stocks Lagging Entera Bio (ENTX) This Year?(Zacks)
2024-05-14 20:00
Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member(Globenewswire)
2024-05-12 19:00
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024(Globenewswire)
2024-05-10 08:53
ENTX Stock Earnings: Entera Bio Beats EPS for Q1 2024(Investorplace)
2024-05-10 04:10
Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates(Globenewswire)
2024-04-26 06:00
Entera Bio Ltd. (ENTX) Stock Slides as Market Rises: Facts to Know Before You Trade(Yahoo Finance)
2024-04-18 06:15
Why the Market Dipped But Entera Bio Ltd. (ENTX) Gained Today(Zacks)
2024-04-15 03:43
Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?(Yahoo Finance)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.